Skip to main content
Public Health
Expert opinion

Scientific Advice on the safety of Homosalate (CAS No 118-56-9, EC No 204-260-8) as a UV-filter in cosmetic products

Final Opinion

Details

Publication date
2 December 2021
Author
Scientific Committee on Consumer Safety (SCCS)

Description

SCCS members: U. Bernauer, L. Bodin, Q. Chaudhry, P.J. Coenraads (Chairperson), M. Dusinska, J. Ezendam, E. Gaffet, C. L. Galli, B. Granum (Rapporteur), E. Panteri, V. Rogiers, Ch. Rousselle, M. Stepnik, T. Vanhaecke, S. Wijnhoven
SCCS external experts: A. Koutsodimou, W. Uter, N. von Goetz
Contact:SANTE-C2-SCCS@ec.europa.eu
On request from: European Commission
SCCS Number: SCCS/1638/21
Adopted on: 2 December 2021

Conclusion of the opinion:

1. In light of the information provided and taking under consideration the concerns related to potential endocrine disrupting properties of Homosalate, does the SCCS consider Homosalate safe when used as a UV-filter in face products (face cream and pump spray) up to a maximum concentration of 7.34 %?

On the basis of safety assessment, and considering the concerns related to potential endocrine disrupting properties of Homosalate, the SCCS is of the opinion that Homosalate is safe as a UV-filter at concentrations up to 7.34% in face cream and pump spray.

2. Alternatively, what is according to the SCCS the maximum concentration considered safe for use of Homosalate as a UV-filter in face products (face cream and pump spray)?

/

Keywords:

SCCS, scientific advice, Homosalate, UV-filter, Regulation 1223/2009, CAS No 118-56-9, EC No 204-260-8

Opinion to be cited as:

SCCS (Scientific Committee on Consumer Safety), Scientific advice on the safety of Homosalate (CAS No 118-56-9, EC No 204-260-8) as a UV-filter in cosmetic products in cosmetic products, final version of 2 December 2021, SCCS/1638/21.

Files

5 JANUARY 2022
sccs_o_260.pdf
English
(367.63 KB - PDF)
Download